Lv1
50 积分 2025-09-01 加入
Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives
1个月前
已完结
Cellular senescence in lung cancer: Molecular mechanisms and therapeutic interventions
1个月前
已完结
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
2个月前
已完结
Exploring gut microbial metabolites as key players in inhibition of cancer progression: Mechanisms and therapeutic implications
2个月前
已完结
Gut microbial metabolites in lung cancer development and immunotherapy: Novel insights into gut-lung axis
2个月前
已完结
Biomarker-Targeted Therapies in Non–Small Cell Lung Cancer: Current Status and Perspectives
2个月前
已完结
Efficacy and safety of immune checkpoint inhibitors for advanced non-small cell lung cancer with or without PD-L1 selection: A systematic review and network meta-analysis
3个月前
已完结
Efficacy and safety of immune checkpoint inhibitors for advanced squamous non-small cell lung cancer: a systematic review and network meta-analysis
3个月前
已完结
Comparison of efficacy and safety of PD-1/PD-L1 combination therapy in first-line treatment of advanced NSCLC: an updated systematic review and network meta-analysis
3个月前
已完结
Comparison of efficacy and safety of PD-1/PD-L1 combination therapy in first-line treatment of advanced NSCLC: an updated systematic review and network meta-analysis
3个月前
已完结
皖公网安备34019202002308
